News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trial For New Device Aimed At Treating Patients With Refractory Angina Starts Off Well, Montreal Heart Institute Study


2/28/2011 8:12:23 AM

Medical News Today -- A team of cardiologists from the Montreal Heart Institute (MHI) have recently started enrolling patients for the Neovasc ReducerTM, designed to treat patients with refractory angina. This innovative treatment method, the first to be carried out in North America and part of an international study (COSIRA trial), shows promise for scores of Canadian patients disabled by refractory angina and who do not have alternatives for alleviating their signs and symptoms symptoms and improving their quality of life.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES